181 related articles for article (PubMed ID: 36508127)
1. Development and validation of a novel nomogram predicting pseudohypoxia type pheochromocytomas and paragangliomas.
Wang Y; Liu L; Chen D; Pang Y; Xu X; Liu J; Li M; Guan X
J Endocrinol Invest; 2023 Jul; 46(7):1361-1371. PubMed ID: 36508127
[TBL] [Abstract][Full Text] [Related]
2. Establishment and evaluation of a novel biomarker-based nomogram for malignant phaeochromocytomas and paragangliomas.
Zhong X; Ye L; Su T; Xie J; Zhou W; Jiang Y; Jiang L; Ning G; Wang W
Clin Endocrinol (Oxf); 2017 Aug; 87(2):127-135. PubMed ID: 28429830
[TBL] [Abstract][Full Text] [Related]
3. A nomogram for predicting the presence of germline mutations in pheochromocytomas and paragangliomas.
Su TW; Zhong X; Ye L; Song W; Jiang L; Xie J; Jiang Y; Zhou W; Zhang C; Wu L; Ning G; Wang W
Endocrine; 2019 Dec; 66(3):666-672. PubMed ID: 31606865
[TBL] [Abstract][Full Text] [Related]
4. Risk factors and a predictive nomogram for hemodynamic instability during adrenalectomy for large pheochromocytomas and paragangliomas: A retrospective cohort study.
Li S; Li Z; Zheng J; Chen X
Eur J Surg Oncol; 2023 Oct; 49(10):106964. PubMed ID: 37369608
[TBL] [Abstract][Full Text] [Related]
5. The clinical characteristics of patients with normotension in pheochromocytomas and paragangliomas.
Zhao L; Zhang T; Meng X; Fan H; Zhang Z; Liu Y; Zhou X; Zhu H
Endocrine; 2023 Apr; 80(1):174-182. PubMed ID: 36749542
[TBL] [Abstract][Full Text] [Related]
6. Nomogram for predicting hemodynamic instability and the association between preoperative 3D printing and hemodynamic instability during laparoscopic adrenalectomy for pheochromocytoma.
Wang Y; Liu L; Pang Y; Chen D; Xu X; Liu J; Guan X
Am J Cancer Res; 2023; 13(4):1602-1610. PubMed ID: 37168353
[TBL] [Abstract][Full Text] [Related]
7. Clinical differences between small and large pheochromocytomas and paragangliomas.
Zhao L; Li Z; Meng X; Fan H; Zhang Z; Zhang Z; Liu Y; Zhou X; Zhu H
Front Endocrinol (Lausanne); 2023; 14():1087506. PubMed ID: 36967797
[TBL] [Abstract][Full Text] [Related]
8. Development and internal validation of a novel predictive model for
Zhou Y; Gao Y; Ma X; Li T; Cui Y; Wang Y; Li M; Zhang D; Tong A
Front Endocrinol (Lausanne); 2023; 14():1285631. PubMed ID: 38179299
[TBL] [Abstract][Full Text] [Related]
9. Factors contributing to development and resolution of dysglycemia in patients with pheochromocytomas and catecholamine-secreting paragangliomas.
Zhao L; Zhang T; Meng X; Zhang Z; Zhou Y; Fan H; Liu Y; Zhou X; Zhu H
Ann Med; 2023 Dec; 55(1):2203945. PubMed ID: 37129505
[TBL] [Abstract][Full Text] [Related]
10. Genetic Characteristics of Incidental Pheochromocytoma and Paraganglioma.
Zhang J; Li M; Pang Y; Wang C; Wu J; Cheng Z; Li X; Lu Z; Liu Y; Guo J; Chen X; He Y; Guan X; Xu X; Wang Y; Liu J; Guo W; Hou Y; Liu L; Jiang J; Gao X
J Clin Endocrinol Metab; 2022 Apr; 107(5):e1835-e1842. PubMed ID: 35106577
[TBL] [Abstract][Full Text] [Related]
11. Novel alternative tools for metastatic pheochromocytomas/paragangliomas prediction.
Cui Y; Zhou Y; Gao Y; Ma X; Wang Y; Zhang X; Zhou T; Chen S; Lu L; Zhang Y; Chang X; Tong A; Li Y
J Endocrinol Invest; 2024 May; 47(5):1191-1203. PubMed ID: 38206552
[TBL] [Abstract][Full Text] [Related]
12. Significance of Alpha-inhibin Expression in Pheochromocytomas and Paragangliomas.
Mete O; Pakbaz S; Lerario AM; Giordano TJ; Asa SL
Am J Surg Pathol; 2021 Sep; 45(9):1264-1273. PubMed ID: 33826547
[TBL] [Abstract][Full Text] [Related]
13. [
Noortman WA; Vriens D; de Geus-Oei LF; Slump CH; Aarntzen EH; van Berkel A; Timmers HJLM; van Velden FHP
Eur Radiol; 2022 Oct; 32(10):7227-7236. PubMed ID: 36001126
[TBL] [Abstract][Full Text] [Related]
14. A Nomogram for Predicting Intraoperative Hemodynamic Instability in Patients With Pheochromocytoma.
Zhang Z; Ye Y; Yu J; Liao S; Pan W; Guo Y; Jiang S; Luo C; Zheng F
Front Endocrinol (Lausanne); 2021; 12():787786. PubMed ID: 35069440
[TBL] [Abstract][Full Text] [Related]
15. A Predictive Nomogram for Red Blood Cell Transfusion in Pheochromocytoma Surgery: A Study on Improving the Preoperative Management of Pheochromocytoma.
Guo Y; You L; Hu H; Tong A; Zhang X; Yan L; Zhang S
Front Endocrinol (Lausanne); 2021; 12():647610. PubMed ID: 33790869
[TBL] [Abstract][Full Text] [Related]
16. Disentangling of Malignancy from Benign Pheochromocytomas/Paragangliomas.
Kim KY; Kim JH; Hong AR; Seong MW; Lee KE; Kim SJ; Kim SW; Shin CS; Kim SY
PLoS One; 2016; 11(12):e0168413. PubMed ID: 27992508
[TBL] [Abstract][Full Text] [Related]
17. Determinants of disease-specific survival in patients with and without metastatic pheochromocytoma and paraganglioma.
Pamporaki C; Prodanov T; Meuter L; Berends AMA; Bechmann N; Constantinescu G; Beuschlein F; Remde H; Januszewicz A; Kerstens MN; Timmers HJLM; Taïeb D; Robledo M; Lenders JWM; Pacak K; Eisenhofer G
Eur J Cancer; 2022 Jul; 169():32-41. PubMed ID: 35500459
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology and Prognosis of Pheochromocytoma/Paraganglioma in Korea: A Nationwide Study Based on the National Health Insurance Service.
Kim JH; Moon H; Noh J; Lee J; Kim SG
Endocrinol Metab (Seoul); 2020 Mar; 35(1):157-164. PubMed ID: 32207276
[TBL] [Abstract][Full Text] [Related]
19. Development and Validation of a Nomogram for Predicting Postoperative Distant Metastasis in Patients with Cervical Cancer.
Zeng W; Huang L; Lin H; Pan R; Liu H; Wen J; Liang Y; Yang H
Med Sci Monit; 2022 Apr; 28():e933379. PubMed ID: 35410987
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-210 May Be a Preoperative Biomarker of Malignant Pheochromocytomas and Paragangliomas.
Ruff SM; Ayabe RI; Malekzadeh P; Good ML; Wach MM; Gonzales MK; Tirosh A; Nilubol N; Pacak K; Kebebew E; Patel D
J Surg Res; 2019 Nov; 243():1-7. PubMed ID: 31146085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
